Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Interplay between pathologies of ovarian cancer and genomics

Prof David Huntsman – University of British Columbia, Vancouver, Canada
Interplay between pathologies of ovarian cancer and genomics ( Prof David Huntsman – University of British Columbia, Vancouver, Canada )
15 Nov 2012

Biology of molecular sub types in ovarian cancer

Prof David Bowtell – Peter MacCallum Cancer Centre, Melbourne, Australia
Biology of molecular sub types in ovarian cancer ( Prof David Bowtell – Peter MacCallum Cancer Centre, Melbourne, Australia )
15 Nov 2012

Sub-typing ovarian cancer

Dr Charles Gourley – University of Edinburgh Cancer Research Center, UK
Sub-typing ovarian cancer ( Dr Charles Gourley – University of Edinburgh Cancer Research Center, UK )
15 Nov 2012

Early stage biomarkers in ovarian cancer

Prof Angelo Paradiso – National Cancer Research Institute, Bari, Italy
Early stage biomarkers in ovarian cancer ( Prof Angelo Paradiso – National Cancer Research Institute, Bari, Italy )
15 Nov 2012

Drug approval process for ovarian cancer

Prof Maria Paolo Costi – University of Modena, Italy
Drug approval process for ovarian cancer ( Prof Maria Paolo Costi – University of Modena, Italy )
15 Nov 2012

Interaction between tumour biology and surgery

Dr Christina Fotopoulou – Charite University Hospital, Berlin, Germany
Interaction between tumour biology and surgery ( Dr Christina Fotopoulou – Charite University Hospital, Berlin, Germany )
15 Nov 2012

Collaborations in clinical trials to bring new drugs to patients earlier

Dr Matt Seymour – National Cancer Research Network
Collaborations in clinical trials to bring new drugs to patients earlier (  Dr Matt Seymour – National Cancer Research Network  )
14 Nov 2012

Therapeutic exercise for patients with advanced cancer

Dr Matthew Maddocks – University of Nottingham, UK
Therapeutic exercise for patients with advanced cancer ( Dr Matthew Maddocks – University of Nottingham, UK  )
14 Nov 2012

Inequalities in cancer incidence, mortality and survival

Dr Michel Coleman - London School of Hygiene and Topical Medicine, London, UK
Inequalities in cancer incidence, mortality and survival ( Dr Michel Coleman - London School of Hygiene and Topical Medicine, London, UK )
14 Nov 2012

Development of future cancer treatments

Dr Herbie Newell - Northern Institute for Cancer Research, Newcastle, UK
Development of future cancer treatments ( Dr Herbie Newell - Northern Institute for Cancer Research, Newcastle, UK )
14 Nov 2012

Tissue donation and clinical trials

Adrienne Morgan – VNCRI & NCRN Consumer Liaison Group
Tissue donation and clinical trials  ( Adrienne Morgan – VNCRI & NCRN Consumer Liaison Group )
14 Nov 2012

Drug susceptibility in cancer cell lines

Dr Lodewyk Wessels – Netherlands Cancer Institute, Amsterdam
Drug susceptibility in cancer cell lines ( Dr Lodewyk Wessels – Netherlands Cancer Institute, Amsterdam )
14 Nov 2012